INS and Alzheimer disease: Another attractive feature of the metabolic/brain insulin resistance hypothesis is that it demystifies the pathophysiology of AD by relating it to other well-recognized systemic diseases, i.e. diabetes mellitus, non-alcoholic steatohepatitis, and metabolic syndrome.